Literature DB >> 22342122

Cognitive endophenotypes of psychosis within dimension and diagnosis.

Elena I Ivleva1, David W Morris, Julian Osuji, Amanda F Moates, Thomas J Carmody, Gunvant K Thaker, Munro Cullum, Carol A Tamminga.   

Abstract

This study sought to characterize the psychosis phenotype, contrasting cognitive features within traditional diagnosis and psychosis dimension in a family sample containing both schizophrenia and psychotic bipolar I disorder. Seventy-six probands with psychosis [44 probands with schizophrenia, 32 probands with psychotic bipolar I disorder] and 55 first-degree relatives [30 relatives of schizophrenia probands, 25 relatives of bipolar probands] were recruited. Standardized clinical and neuropsychological measures were administered. No differences in cognitive performance emerged between probands with schizophrenia and probands with psychotic bipolar disorder, or between relatives of probands with schizophrenia and relatives of probands with bipolar disorder in the domains of working and declarative memory, executive function and attention. Relatives overall showed higher cognitive performance compared to probands, as expected. However, when we segmented the probands and relatives along a psychosis dimension, independent of diagnostic groups, results revealed lower cognitive performance in probands compared to relatives without psychosis spectrum disorders, whereas relatives with psychosis spectrum disorders showed an intermediate level of performance across all cognitive domains. In this study, cognitive performance did not distinguish either probands or their first-degree relatives within traditional diagnostic groups (schizophrenia and psychotic bipolar disorder), but distinguished probands and relatives with and without lifetime psychosis manifestations independent of diagnostic categories. These data support the notion that schizophrenia and psychotic bipolar disorder present a clinical continuum with overlapping cognitive features defining the psychosis phenotype. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22342122      PMCID: PMC3351583          DOI: 10.1016/j.psychres.2011.08.021

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  46 in total

1.  Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder.

Authors:  C T S Kumar; T Christodoulou; N S Vyas; M Kyriakopoulos; R Corrigall; A Reichenberg; S Frangou
Journal:  Schizophr Res       Date:  2010-08-02       Impact factor: 4.939

2.  Neuropsychological function in euthymic patients with bipolar disorder.

Authors:  I N Ferrier; B R Stanton; T P Kelly; J Scott
Journal:  Br J Psychiatry       Date:  1999-09       Impact factor: 9.319

3.  The efficiency of simulation-based multiple comparisons.

Authors:  D Edwards; J J Berry
Journal:  Biometrics       Date:  1987-12       Impact factor: 2.571

4.  Genetic theorizing and schizophrenia.

Authors:  I I Gottesman; J Shields
Journal:  Br J Psychiatry       Date:  1973-01       Impact factor: 9.319

5.  Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis.

Authors:  Evgenia Stefanopoulou; Andiappan Manoharan; Sabine Landau; John R Geddes; Guy Goodwin; Sophia Frangou
Journal:  Int Rev Psychiatry       Date:  2009

6.  Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families.

Authors:  David C Glahn; Laura Almasy; Marcela Barguil; Elizabeth Hare; Juan Manuel Peralta; Jack W Kent; Albana Dassori; Javier Contreras; Adriana Pacheco; Nuria Lanzagorta; Humberto Nicolini; Henriette Raventós; Michael A Escamilla
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 7.  Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary.

Authors:  Elena I Ivleva; David W Morris; Amanda F Moates; Trisha Suppes; Gunvant K Thaker; Carol A Tamminga
Journal:  Neurosci Biobehav Rev       Date:  2009-11-30       Impact factor: 8.989

Review 8.  Information processing and attention dysfunctions in schizophrenia.

Authors:  D L Braff
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

9.  Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.

Authors:  Nienke Jabben; Baer Arts; Lydia Krabbendam; Jim van Os
Journal:  Bipolar Disord       Date:  2009-03       Impact factor: 6.744

10.  Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: high morbidity risks for unspecified functional psychoses and schizophrenia.

Authors:  G Thaker; H Adami; M Moran; A Lahti; S Cassady
Journal:  Am J Psychiatry       Date:  1993-01       Impact factor: 18.112

View more
  26 in total

1.  Explicit and implicit reinforcement learning across the psychosis spectrum.

Authors:  Deanna M Barch; Cameron S Carter; James M Gold; Sheri L Johnson; Ann M Kring; Angus W MacDonald; Diego A Pizzagalli; J Daniel Ragland; Steven M Silverstein; Milton E Strauss
Journal:  J Abnorm Psychol       Date:  2017-04-13

2.  Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders.

Authors:  Dominique Arion; Zhiguang Huo; John F Enwright; John P Corradi; George Tseng; David A Lewis
Journal:  Biol Psychiatry       Date:  2017-04-04       Impact factor: 13.382

3.  Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction.

Authors:  Alana M Shepherd; Yann Quidé; Kristin R Laurens; Nicole O'Reilly; Jesseca E Rowland; Philip B Mitchell; Vaughan J Carr; Melissa J Green
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

Review 4.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

5.  A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.

Authors:  Faith M Hanlon; Ronald A Yeo; Nicholas A Shaff; Christopher J Wertz; Andrew B Dodd; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Swala Abrams; Jingyu Liu; Andrew R Mayer
Journal:  Schizophr Res       Date:  2019-01-31       Impact factor: 4.939

6.  Differentiating between clinical and behavioral phenotypes in first-episode psychosis during maintenance of visuospatial working memory.

Authors:  Maria Jalbrzikowski; Vishnu P Murty; Patricia L Stan; Jusmita Saifullan; Daniel Simmonds; William Foran; Beatriz Luna
Journal:  Schizophr Res       Date:  2017-11-11       Impact factor: 4.939

Review 7.  Transdiagnostic impairment of cognitive control in mental illness.

Authors:  Lisa M McTeague; Madeleine S Goodkind; Amit Etkin
Journal:  J Psychiatr Res       Date:  2016-08-05       Impact factor: 4.791

8.  Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants.

Authors:  Mei-Hua Hall; Deborah L Levy; Dean F Salisbury; Steve Haddad; Patience Gallagher; Mary Lohan; Bruce Cohen; Dost Ongür; Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-11-08       Impact factor: 3.568

9.  Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer).

Authors:  Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2014-02-20       Impact factor: 9.306

Review 10.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.